Veltassa
- Business Wire
First patient enrolled in CARE-HK in HF to evaluate role of Veltassa® (patiromer) in enabling RAASi treatment
CARE-HK in heart failure (HF) is the first global registry of around 5,000 patients with chronic HF who have or…
Read More » - Business
VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement
Bad Homburg, Germany & St. Gallen, Switzerland: Veltassa® is a well-tolerated1 and effective2 oral calcium potassium binder for the treatment of hyperkalemia supported…
Read More »